Vaccine Manufacture and Supply – News and Features

Drew Burch discusses how next-gen mRNA technology is one of the most valuable tools to combat and control disease outbreaks and why continued investment in this field is crucial for maintaining our pandemic preparedness.

This article will outline how automation is currently adopted in vaccine development, including workflows and methods to improve efficiency. In addition, it will explore future opportunities to implement automation when developing vaccines.

The International Vaccine Institute (IVI) began clinical development of DuoChol, a new low-cost oral cholera vaccine (OCV) in capsule form.

A mobile vaccine printer, developed by MIT researchers, could be used to scale up vaccine production and help vaccines reach more people.

With the world of science rapidly evolving, and a new year beginning, we look at the trends breaking through right now, asking experts: where is the world of science headed?

This article will explore some of the key challenges associated with vaccine storage and why this differs across different types of vaccines.

As vaccine technologies evolve, sophisticated analytical tools are needed to support vaccine discovery, development and manufacturing. In this article, we explore the role of chromatography in the vaccine pipeline.

Scott Ripley discusses how overcoming mRNA challenges can help to achieve public health preparedness and long-term manufacturing goals.

According to a study, vaccination campaign budgets for disadvantaged, vulnerable populations need to be raised to reach the maximum health benefit for everyone.

Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, is filing patent infringement lawsuits against Pfizer and BioNTech in the United States District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany.